ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Options Flow

Live Options Flow

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
S&P TSX Capped Composite...
35.89
0.70%
US Tech 100
18,163.60
0.52%
S&P 500
5,323.61
0.38%
US Dollar vs CAD
1.36126
0.03%
Bitcoin
67,265.43
1.67%
Registration Strip Icon for smarter Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Fortress Biotech Inc (FBIO)

  7. Fortress Biotech Inc (FBIO) News

FBIO

Fortress Biotech (FBIO)

Fortress Biotech Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:FBIO
DateTimeSourceHeadlineSymbolCompany
05/16/20247:30AMGlobeNewswire Inc.Avenue Therapeutics Announces Last Patient Last Visit in Phase 1b/2a Clinical Trial of AJ201 for the Treatment of Spinal and Bulbar Muscular Atrophy (Kennedy's Disease)NASDAQ:FBIOFortress Biotech Inc
05/16/20247:00AMGlobeNewswire Inc.Fortress Biotech to Participate in the Alliance Global Partners’ (A.G.P.) Virtual Healthcare Company ShowcaseNASDAQ:FBIOFortress Biotech Inc
05/15/20243:15PMGlobeNewswire Inc.Fortress Biotech Reports First Quarter 2024 Financial Results and Recent Corporate HighlightsNASDAQ:FBIOFortress Biotech Inc
05/15/20243:01PMGlobeNewswire Inc.Journey Medical Corporation to Participate in the Alliance Global Partners’ (A.G.P.) Virtual Healthcare Company ShowcaseNASDAQ:FBIOFortress Biotech Inc
05/15/20247:30AMGlobeNewswire Inc.Avenue Therapeutics Reports First Quarter 2024 Financial Results and Recent Corporate HighlightsNASDAQ:FBIOFortress Biotech Inc
05/14/20247:30AMGlobeNewswire Inc.Fortress Biotech Announces First Patient Dosed in Multi-Center Phase 2 Study of Triplex for Control of CMV in Patients Undergoing Liver TransplantationNASDAQ:FBIOFortress Biotech Inc
05/13/20243:01PMGlobeNewswire Inc.Journey Medical Corporation Reports First Quarter 2024 Financial Results and Recent Corporate HighlightsNASDAQ:FBIOFortress Biotech Inc
05/07/20247:30AMGlobeNewswire Inc.Journey Medical Corporation to Announce First Quarter 2024 Financial Results on May 13, 2024NASDAQ:FBIOFortress Biotech Inc
05/02/20243:01PMGlobeNewswire Inc.Mustang Bio Announces Closing of $4 Million Public OfferingNASDAQ:FBIOFortress Biotech Inc
05/01/20243:01PMGlobeNewswire Inc.Journey Medical Corporation Appoints Joseph Benesch as Chief Financial OfficerNASDAQ:FBIOFortress Biotech Inc
04/29/20247:00PMGlobeNewswire Inc.Mustang Bio Announces Pricing of $4 Million Public OfferingNASDAQ:FBIOFortress Biotech Inc
04/29/20247:00AMGlobeNewswire Inc.Avenue Therapeutics Announces Exercise of Warrants for $4.4 Million in Gross ProceedsNASDAQ:FBIOFortress Biotech Inc
04/25/20247:30AMGlobeNewswire Inc.Journey Medical Corporation to Present at the Planet MicroCap Showcase: Vegas 2024NASDAQ:FBIOFortress Biotech Inc
04/24/20246:30AMGlobeNewswire Inc.Avenue Therapeutics Announces Reverse Stock SplitNASDAQ:FBIOFortress Biotech Inc
03/28/20243:05PMGlobeNewswire Inc.Fortress Biotech Reports 2023 Financial Results and Recent Corporate HighlightsNASDAQ:FBIOFortress Biotech Inc
03/28/20248:00AMGlobeNewswire Inc.Mustang Bio Announces Vision for CAR T-Cell Therapy Platform Expansion into Autoimmune DiseasesNASDAQ:FBIOFortress Biotech Inc
03/25/20247:30AMGlobeNewswire Inc.Avenue Therapeutics to Host Virtual Key Opinion Leader (KOL) Event on April 4, 2024NASDAQ:FBIOFortress Biotech Inc
03/21/20243:01PMGlobeNewswire Inc.Journey Medical Corporation Reports Full-Year 2023 Financial Results and Recent Corporate HighlightsNASDAQ:FBIOFortress Biotech Inc
03/18/20243:05PMGlobeNewswire Inc.Avenue Therapeutics Reports Full Year 2023 Financial Results and Recent Corporate HighlightsNASDAQ:FBIOFortress Biotech Inc
03/18/20247:30AMGlobeNewswire Inc.Journey Medical Corporation Announces U.S. FDA Acceptance of New Drug Application for DFD-29 for the Treatment of RosaceaNASDAQ:FBIOFortress Biotech Inc
03/15/20247:30AMGlobeNewswire Inc.Journey Medical Corporation to Announce Year End 2023 Financial Results on March 21, 2024NASDAQ:FBIOFortress Biotech Inc
03/15/20247:15AMGlobeNewswire Inc.Avenue Therapeutics Receives Positive Listing Determination from NasdaqNASDAQ:FBIOFortress Biotech Inc
03/13/20247:30AMGlobeNewswire Inc.Journey Medical Corporation to Participate in the 36th Annual ROTH ConferenceNASDAQ:FBIOFortress Biotech Inc
03/12/20247:30AMGlobeNewswire Inc.Fortress Biotech to Participate in 36th Annual ROTH ConferenceNASDAQ:FBIOFortress Biotech Inc
03/11/20247:30AMGlobeNewswire Inc.Journey Medical Corporation Announces Presentation of Data from Phase 1 Clinical Trial Assessing the Impact of DFD-29 (Minocycline Hydrochloride Modified Release Capsules, 40 mg) on Microbial Flora of Healthy Adults at 2024 AAD Annual MeetingNASDAQ:FBIOFortress Biotech Inc
03/11/20247:00AMGlobeNewswire Inc.Avenue Therapeutics to Present BAER-101 Preclinical Data at American Society for Experimental Neurotherapeutics (ASENT) 2024 Annual MeetingNASDAQ:FBIOFortress Biotech Inc
03/07/20246:30AMGlobeNewswire Inc.Mustang Bio Announces Publication in Nature Medicine of Data from Phase 1 Trial Evaluating MB-101 IL13Rα2-targeted CAR T-Cells in High-Grade GliomaNASDAQ:FBIOFortress Biotech Inc
03/04/20247:30AMGlobeNewswire Inc.Fortress Biotech and Cyprium Therapeutics Announce $4.1 Million Grant from NINDS to Further Development of AAV-ATP7A Gene Therapy for Menkes DiseaseNASDAQ:FBIOFortress Biotech Inc
02/22/20247:30AMGlobeNewswire Inc.Avenue Therapeutics Announces Publication in Drug Development Research Highlighting First-In-Class Preclinical Data of BAER-101 in a Translational Model of Absence EpilepsyNASDAQ:FBIOFortress Biotech Inc
01/11/20247:30AMGlobeNewswire Inc.Mustang Bio to Participate in the B. Riley Securities 4th Annual Oncology ConferenceNASDAQ:FBIOFortress Biotech Inc
 Showing the most relevant articles for your search:NASDAQ:FBIO

Your Recent History

EU
ACAPK
Credit Agricole SA 1.10%...
ASX
BUGN
NASDAQ
SKYY
First Trust Cloud Comput...
NASDAQ
FROXMX
Ubs Cio Top Picks Series...
BIT
P1XSN8
NLBNPIT1XSN8 20240620 16...
BIT
Q00343
Leonteq Securities
ASX
EWE
EU
AAF7L
Credit Agricole CIB Fina...
LSE
93KY
Puma.fin.a2nt31
EU
FR001400OF19
Pluxee Bond 3750% until ...
BIT
P20771
NLBNPIT20771 20991231 17...
LSE
QI83
Morg.st.b.v 26
EU
FR1CIBLU0119
Credit Agricole CIB Fina...
LSE
66ZU
Morgan St. 25
EU
ACAPM
Credit Agricole SA Casa4...
EU
FR0014002JP9
Credit Agricole Consumer...
Delayed Upgrade Clock
ADVFN Logo

Canada
Company
Business
Popular
Get The App

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved